Mitsuru Hashida

2.3k total citations
40 papers, 1.9k citations indexed

About

Mitsuru Hashida is a scholar working on Molecular Biology, Pharmaceutical Science and Hepatology. According to data from OpenAlex, Mitsuru Hashida has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Pharmaceutical Science and 7 papers in Hepatology. Recurrent topics in Mitsuru Hashida's work include Advanced Drug Delivery Systems (10 papers), Advancements in Transdermal Drug Delivery (8 papers) and RNA Interference and Gene Delivery (5 papers). Mitsuru Hashida is often cited by papers focused on Advanced Drug Delivery Systems (10 papers), Advancements in Transdermal Drug Delivery (8 papers) and RNA Interference and Gene Delivery (5 papers). Mitsuru Hashida collaborates with scholars based in Japan, Germany and Türkiye. Mitsuru Hashida's co-authors include Yoshinobu Takakura, Kenji Kawabata, Hitoshi Sezaki, Fumiyoshi Yamashita, Makiya Nishikawa, Ram I. Mahato, Akira Takagi, Shigeru Kawakami, Shintaro Fumoto and Toshiyasu Sakane and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mitsuru Hashida

40 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuru Hashida Japan 23 1.1k 344 323 305 189 40 1.9k
Susumu Hama Japan 25 1.0k 0.9× 311 0.9× 209 0.6× 226 0.7× 71 0.4× 55 1.8k
Pascal Bailon United States 20 1.1k 0.9× 114 0.3× 73 0.2× 208 0.7× 321 1.7× 43 2.8k
Jie Tang China 26 1.3k 1.1× 96 0.3× 152 0.5× 471 1.5× 245 1.3× 82 2.4k
Aihua Zou China 25 965 0.8× 426 1.2× 103 0.3× 215 0.7× 221 1.2× 56 1.8k
Ali Jahanian‐Najafabadi Iran 25 926 0.8× 100 0.3× 83 0.3× 300 1.0× 160 0.8× 126 2.1k
Feng‐Qian Li China 22 666 0.6× 291 0.8× 144 0.4× 120 0.4× 98 0.5× 51 1.2k
Hee Dong Han South Korea 33 1.4k 1.2× 122 0.4× 173 0.5× 623 2.0× 496 2.6× 86 2.9k
Pierre Lemieux Canada 18 1.1k 0.9× 348 1.0× 104 0.3× 334 1.1× 104 0.6× 38 1.8k
Kazuaki Kajimoto Japan 27 1.1k 1.0× 143 0.4× 229 0.7× 253 0.8× 83 0.4× 80 2.0k
Jim Klostergaard United States 29 1.2k 1.1× 102 0.3× 44 0.1× 296 1.0× 496 2.6× 110 2.4k

Countries citing papers authored by Mitsuru Hashida

Since Specialization
Citations

This map shows the geographic impact of Mitsuru Hashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuru Hashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuru Hashida more than expected).

Fields of papers citing papers by Mitsuru Hashida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuru Hashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuru Hashida. The network helps show where Mitsuru Hashida may publish in the future.

Co-authorship network of co-authors of Mitsuru Hashida

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuru Hashida. A scholar is included among the top collaborators of Mitsuru Hashida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuru Hashida. Mitsuru Hashida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamashita, Fumiyoshi, et al.. (2021). Minocycline Hydrochloride Controlled-release Microsphere Preparation Process Optimization Based on the Robust Design Method. Turkish Journal of Pharmaceutical Sciences. 18(6). 752–760. 5 indexed citations
3.
Ogawara, Ken‐ichi, Kentaro Furumoto, Yoshinobu Takakura, et al.. (2001). Surface hydrophobicity of particles is not necessarily the most important determinant in their in vivo disposition after intravenous administration in rats. Journal of Controlled Release. 77(3). 191–198. 40 indexed citations
4.
Kawakami, Shigeru, et al.. (2001). Enhanced Gene Transfection in Macrophages Using Mannosylated Cationic Liposome-Polyethylenimine-Plasmid DNA Complexes. Journal of drug targeting. 9(3). 201–207. 35 indexed citations
5.
Takahashi, Yoshiteru, et al.. (2000). Effect of Vehicle Properties on Skin Penetration of Emedastine.. Biological and Pharmaceutical Bulletin. 23(10). 1224–1228. 11 indexed citations
6.
Kawakami, Shigeru, Shintaro Fumoto, Makiya Nishikawa, Fumiyoshi Yamashita, & Mitsuru Hashida. (2000). In Vivo Gene Delivery to the Liver Using Novel Galactosylated Cationic Liposomes. Pharmaceutical Research. 17(3). 306–313. 139 indexed citations
7.
Yamashita, Fumiyoshi, et al.. (1999). Theoretical Analysis of the Effect of Cutaneous Metabolism on Skin Permeation of Parabens Based on a Two-Layer Skin Diffusion/Metabolism Model.. Biological and Pharmaceutical Bulletin. 22(3). 281–287. 24 indexed citations
8.
Takagi, Akira, et al.. (1998). In vivo fate of folate–BSA in non‐tumor‐ and tumor‐bearing mice. Journal of Pharmaceutical Sciences. 87(12). 1521–1526. 35 indexed citations
9.
Mahato, Ram I., Shigeo Takemura, Ken Akamatsu, et al.. (1997). Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(l-lysine). Biochemical Pharmacology. 53(6). 887–895. 85 indexed citations
10.
Hirabayashi, Hideki, Makiya Nishikawa, Yoshinobu Takakura, & Mitsuru Hashida. (1996). Development and Pharmacokinetics of Galactosylated Poly-L-Glutamic Acid as a Biodegradable Carrier for Liver-Specific Drug Delivery. Pharmaceutical Research. 13(6). 880–884. 50 indexed citations
11.
Kondo, Satoshi, et al.. (1996). Mannosylated Superoxide Dismutase Inhibits Hepatic Reperfusion Injury in Rats. Journal of Surgical Research. 60(1). 36–40. 22 indexed citations
12.
Nomura, Takehiko, et al.. (1996). Pharmacokinetic Analysis of Drug Disposition After Intratumoral Injection in a Tissue-Isolated Tumor Perfusion System. Pharmaceutical Research. 13(10). 1438–1444. 13 indexed citations
13.
Kawabata, Kenji, Yoshinobu Takakura, & Mitsuru Hashida. (1995). The Fate of Plasmid DNA After Intravenous Injection in Mice: Involvement of Scavenger Receptors in Its Hepatic Uptake. Pharmaceutical Research. 12(6). 825–830. 374 indexed citations
14.
Koyama, Yasuo, et al.. (1994). Comparative Analysis of Percutaneous Absorption Enhancement by d-Limonene and Oleic Acid Based on a Skin Diffusion Model. Pharmaceutical Research. 11(3). 377–383. 43 indexed citations
15.
16.
Endo, Kaori, et al.. (1992). Effect of Chronic Administration of Phenobarbital on the Hepatobiliary Transport of Phenol Red: Assessment by Statistical Moment Analysis. Pharmaceutical Research. 9(7). 908–914. 8 indexed citations
17.
Sakane, Toshiyasu, et al.. (1991). The Transport of a Drug to the Cerebrospinal Fluid Directly from the Nasal Cavity: The Relation to the Lipophilicity of the Drug.. Chemical and Pharmaceutical Bulletin. 39(9). 2456–2458. 114 indexed citations
18.
Takakura, Yoshinobu, et al.. (1991). Hepatic Disposition Characteristics of Electrically Charged Macromolecules in Rat in Vivo and in the Perfused Liver. Pharmaceutical Research. 8(4). 437–444. 66 indexed citations
19.
Hashida, Mitsuru, et al.. (1990). Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran.. Journal of Pharmacobio-Dynamics. 13(7). 441–447. 15 indexed citations
20.
Higaki, Kazutaka, et al.. (1990). Effect of medium-chain glycerides on the membrane transport of D-glucose and sulfanilic acid in the intestinal brush-border membrane vesicles.. Journal of Pharmacobio-Dynamics. 13(1). 57–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026